title: Reversible myocardial dysfunction following intraocular bevacizumab administration.
abstract: Heart failure has been reported as a rare side effect of bevacizumab, a chemotherapeutic agent, used in the treatment of breast cancer. However, reversible left ventricular systolic dysfunction with a pattern similar to stress-induced cardiomyopathy has not been reported. The etiopathogenesis of stress-induced cardiomyopathy is poorly understood. Given this uncertainty, we should always look out for other potential offenders causing similar presentation, rather than label all of them as "stress-induced".
authors.affiliation: Department of Cardiology, Baystate Medical Center, TUFTS University, Springfield, MA, USA.
authors.forename: Srikanth C
authors.initials: SC
authors.lastname: Penumetsa
authors.forename: Mohammad Z
authors.initials: MZ
authors.lastname: Hoque
authors.forename: Gregory
authors.initials: G
authors.lastname: Giugliano
keywords: Bevacizumab; Heart failure; Stress-induced cardiomyopathy
references.citation: J Clin Oncol. 2011 Feb 20;29(6):632-8
references.pmid: 21205755
references.citation: N Engl J Med. 2005 Feb 10;352(6):539-48
references.pmid: 15703419
references.citation: Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):22-9
references.pmid: 18094670
references.citation: Ophthalmology. 2009 Jun;116(6):1226.e1
references.pmid: 19486800
references.citation: Retina. 2006 May-Jun;26(5):495-511
references.pmid: 16770255
references.citation: Retina. 2007 Apr-May;27(4):439-44
references.pmid: 17420695
references.citation: Heart. 2009 Sep;95(17):1436-41
references.pmid: 19468013
references.citation: Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):81-7
references.pmid: 17674014